The Role of Biosimilars in Uveitis: Long-Term Real-World Outcomes of the Switch From Original to Biosimilar TNF-Alpha Inhibitors

Background: Recent expiry of patents for tumor necrosis factor (TNF)-α inhibitors has led to the employment of biosimilars in clinical practice. The aim of the study was to identify any change in the control of ocular inflammatory manifestations among patients with non-infectious uveitis switching f...

Descripción completa

Detalles Bibliográficos
Autores principales: Fabiani, Claudia, Vitale, Antonio, Emmi, Giacomo, Sgheri, Arianna, Lopalco, Giuseppe, Sota, Jurgen, Guerriero, Silvana, Iannone, Florenzo, Frediani, Bruno, Vannozzi, Lorenzo, Bianco, Maria Teresa, Giovannini, Valtere, Tosi, Gian Marco, Cantarini, Luca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6913067/
https://www.ncbi.nlm.nih.gov/pubmed/31920658
http://dx.doi.org/10.3389/fphar.2019.01468

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6913067/
https://www.ncbi.nlm.nih.gov/pubmed/31920658
http://dx.doi.org/10.3389/fphar.2019.01468

Ejemplares similares